ArticleSpine2026
Prospective, Multicenter Study of Two-Level Cervical Arthroplasty With a PEEK-On-Ceramic Cervical Total Disc Replacement: Five-Year Follow-Up.
Article in Spine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03123549 (Clinical Study Protocol for the Investigation Of The Two Level Simplify® Cervical Artificial Disc), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Clinical Study Protocol for the Investigation Of The Two Level Simplify® Cervical Artificial Disc
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
STUDY
designProspective, nonrandomized cohort analysis.
objectiveTo evaluate five-year outcomes of patients treated with a polyetheretherketone (PEEK)-on-ceramic cTDR device at two levels for radiculopathy and/or myelopathy.
backgroundCervical total disc replacement (cTDR) has gained acceptance as a treatment for symptomatic cervical degenerative disc disease (DDD). Long-term follow-up studies are required to further assess clinical and radiographic outcomes, specifically for patients treated at two consecutive levels.
methodsPatients implanted with Simplify Cervical Disc at two levels from C3 to 7 as part of a Food and Drug Administration investigational device exemption trial (NCT03123549) were contacted, consented, and prospectively followed from 36 to 60 months.
resultsOf 181 patients treated, 80% (144) completed five-year follow-up. Composite clinical success was 86% at 60 months versus 88% at 24 months. At 60 months, 95% had a minimum 15-point improvement in Neck Disability Index compared with 93% at 24 months. Mean neck pain improvement at 24 months (-6.1 on a 10-point numeric scale) was maintained at 60 months. Similarly, improvements in arm pain scores were also maintained from -5.7 at 24 months to -6.2 at 60 months. The cumulative five-year index level reoperation rate was 5% (1%/year) and the adjacent level reoperation rate was 2.2% (0.4%/year). Segmental range of motion was maintained at both operated segments through five years, with an average of 9.0° at superior and 8.7° at inferior levels. Bridging bone was identified in 1% of both the superior and inferior levels, 6% of superior levels only, and 6% of inferior levels only.
conclusionsThis intermediate five-year follow-up study augments previously reported two-year results, supporting that the Simplify cTDR is safe and effective for the treatment of two-level symptomatic cervical DDD. Statistically significant improvements in pain and disability at two-year postoperative were maintained or improved at five years with preservation of motion and low reoperation rates at index and adjacent levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.